In non-endemic regions, IgM-based tests can be used in clinical surveillance, with a high probability that positive results indicate recent infections (during the last 2–3 months) (Dutra et al., 2009; Tuan et al., 2015; Wang et al., 2015; Pang et al., 2017). The gene discussed is CD40LG; the disease is infection.